# Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy

> **NCT06969326** · PHASE3 · RECRUITING · sponsor: **Women and Infants Hospital of Rhode Island** · enrollment: 48 (estimated)

## Conditions studied

- Postoperative Bleeding
- Gender Dysphoria
- Hysterectomy

## Interventions

- **DRUG:** Use of topical estradiol
- **OTHER:** No intervention

## Key facts

- **NCT ID:** NCT06969326
- **Lead sponsor:** Women and Infants Hospital of Rhode Island
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-09-01
- **Final completion:** 2026-12-01
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06969326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06969326, "Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06969326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*